| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 529.1 | 465.8 | 370.1 |
| Other income | 8.7 | 3.1 | 1.5 |
| Total income | 537.8 | 468.9 | 371.7 |
| Profit before exceptional items & tax | 104.0 | 98.1 | 64.4 |
| Exceptional items | -0.4 | 0.0 | 0.0 |
| Profit before tax | 103.5 | 98.1 | 64.4 |
| Net profit | 79.2 | 100.9 | 44.1 |
| Operating margin | 19.2% | 20.9% | 17.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +79.60% |
|---|---|
| Net profit, quarter on quarter | -21.50% |
| Revenue, year on year | +43.00% |
| Operating profit, year on year | +51.50% |
| Operating profit, quarter on quarter | +0.30% |
BSE results filing, NSE: SHILPAMED. Figures extracted from the filing.
Shilpa Medicare Ltd: key numbers
- Share price
- ₹941.90
- Market cap
- ₹18,422 Cr
- Revenue (annual)
- ₹1,539 Cr
- Net profit (annual)
- ₹243.3 Cr
- P/E (TTM)
- 62.0×Sector 37.9×
- Promoter holding
- 40.13%+0.00% QoQ
- FII holding
- 12.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shilpa Medicare Ltd
All →Shilpa Medicare Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 538 cr (+45% YoY), EBITDA INR 151 cr (28% margin), PAT INR 79 cr (+80%). 1HFY27 total income INR 1,007 cr (+44%). Strategy: complex FDF launches, CDMO, biologics, rHA.
Shilpa Medicare Board Meeting Date
Shilpa Medicare's board meeting is scheduled for 5 November 2026 to approve Q2 and H1 unaudited financial results. The trading window remains closed until 7 November 2026.
Shilpa Medicare Business Update
Shilpa Medicare Limited’s Unit 4 in Jadcherla received GMP certification from AGES, Austria, following a successful inspection. This milestone enables operations for European and global markets.
Shilpa Medicare Other Announcement
Shilpa Medicare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Shilpa Medicare Other Announcement
Shilpa Medicare Ltd KMP Alpesh Maheshkumar Dalal sold 4,000 equity shares via market sale. The transaction was valued at Rs.0.42 Crore and executed on the NSE.
- Value
- ₹0.42 Cr
Shilpa Medicare Share Pledge
The company's promoters reported the release of encumbrance on 30,00,000 equity shares held by them. This reduction in pledged shares signals a change in promoter leverage.